A detailed history of Tekla Capital Management LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Tekla Capital Management LLC holds 343,695 shares of MRNA stock, worth $22.6 Million. This represents 1.65% of its overall portfolio holdings.

Number of Shares
343,695
Previous 322,217 6.67%
Holding current value
$22.6 Million
Previous $49.5 Million 15.62%
% of portfolio
1.65%
Previous 1.9%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 10, 2023

BUY
$118.5 - $160.53 $2.55 Million - $3.45 Million
21,478 Added 6.67%
343,695 $41.8 Million
Q1 2023

May 10, 2023

BUY
$135.66 - $197.02 $7.77 Million - $11.3 Million
57,290 Added 21.62%
322,217 $49.5 Million
Q4 2022

Feb 10, 2023

SELL
$118.38 - $210.04 $5.92 Million - $10.5 Million
-49,997 Reduced 15.88%
264,927 $47.6 Million
Q3 2022

Nov 01, 2022

SELL
$118.07 - $194.18 $1.61 Million - $2.64 Million
-13,600 Reduced 4.14%
314,924 $37.2 Million
Q1 2022

May 13, 2022

SELL
$126.46 - $235.05 $27.6 Million - $51.3 Million
-218,100 Reduced 39.9%
328,524 $56.6 Million
Q4 2021

Feb 14, 2022

BUY
$225.82 - $368.51 $19.7 Million - $32.1 Million
87,168 Added 18.97%
546,624 $139 Million
Q3 2021

Nov 12, 2021

SELL
$221.9 - $484.47 $1.4 Million - $3.06 Million
-6,321 Reduced 1.36%
459,456 $177 Million
Q2 2021

Aug 13, 2021

SELL
$129.91 - $234.98 $847,662 - $1.53 Million
-6,525 Reduced 1.38%
465,777 $109 Million
Q1 2021

May 14, 2021

BUY
$109.18 - $185.98 $24.5 Million - $41.7 Million
224,110 Added 90.3%
472,302 $61.8 Million
Q4 2020

Feb 12, 2021

SELL
$65.74 - $169.86 $13.9 Million - $36 Million
-212,167 Reduced 46.09%
248,192 $25.9 Million
Q3 2020

Nov 13, 2020

SELL
$54.34 - $94.85 $1.75 Million - $3.05 Million
-32,147 Reduced 6.53%
460,359 $32.6 Million
Q2 2020

Aug 13, 2020

BUY
$29.67 - $80.0 $7.07 Million - $19.1 Million
238,360 Added 93.79%
492,506 $31.6 Million
Q1 2020

May 14, 2020

BUY
$17.78 - $31.58 $4.52 Million - $8.03 Million
254,146 New
254,146 $7.61 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Tekla Capital Management LLC Portfolio

Follow Tekla Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tekla Capital Management LLC with notifications on news.